Skip to main content

CCTG New Investigator Cancer Trials Practicum

Congratulations to the 2019-2020 New Investigator Cancer Trials Practicum graduates!
On behalf of the entire CCTG network, we extend our congratulations to the 2019-2020 New Investigator Cancer Trials Practicum graduates.

 

Thai-HoaTran

Dr. Tran is Pediatric Hematologist-Oncologist, Leukemia Program, at CHU Sainte-Justine and Clinical Adjunct Professor, Department of Pediatrics, Université de Montréal.

 

Jacques Raphael

Dr. Raphael is a Medical Oncologist at London Regional Cancer Program. Assistant Professor of Oncology, Schulich School of Medicine & Dentistry, Western University. His research interests include breast and Lung Cancer particularly in early phase drug trials and biomarker studies.

Ayesha Bashir

Dr. Bashir is an Oncologist with Allan Blair Cancer Centre in Regina and Assistant Professor of Medical Oncology at the University of Saskatchewan.

Ali Hosni Abdalaty

Dr. Hosni Abdalaty is an Assistant Professor at the University of Toronto and Radiation Oncologist with Princess Margaret Cancer Centre and the Radiation Medicine Program at UHN.

Aly Khan Lalani

Dr. Lalani is an Assistant Professor at McMaster University and a Medical Oncologist at the Juravinski Cancer Centre.

Terry Ng

Dr. Terry Ng is an Assistant Professor at the University of Ottawa and a Clinician-Investigator in the Department of Medicine. Dr. Ng’s research interests have focused on treatment-related adverse events.

The New Investigator Clinical Trials Practicum is designed to provide better engagement and training of new investigators with practical work in the cancer clinical trial field. The purpose is to deliver a training program that includes practical trial experience at cancer sites throughout Canada over a one-year period. This unique program is the only one of its kind in Canada and will enable the best and brightest new Canadian oncology researchers to acquire training and experience.

We wish our recent graduates the very best and look forward to working with them in developing and leading clinical trials that matter!